Baxter International Inc. (BAX)
Automate Your Wheel Strategy on BAX
With Tiblio's Option Bot, you can configure your own wheel strategy including BAX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BAX
- Rev/Share 21.2222
- Book/Share 14.2164
- PB 1.5958
- Debt/Equity 1.3286
- CurrentRatio 2.2964
- ROIC -0.0012
- MktCap 11695151559.0
- FreeCF/Share 0.6491
- PFCF 35.1206
- PE -75.3614
- Debt/Assets 0.4621
- DivYield 0.0299
- ROE -0.0212
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | BAX | Stifel | Buy | Hold | -- | $25 | Aug. 4, 2025 |
| Downgrade | BAX | Goldman | Buy | Neutral | -- | $25 | Aug. 1, 2025 |
| Resumed | BAX | Goldman | -- | Buy | -- | $42 | Feb. 26, 2025 |
| Upgrade | BAX | Argus | Hold | Buy | -- | -- | Feb. 24, 2025 |
| Resumed | BAX | Barclays | -- | Overweight | -- | $39 | Feb. 20, 2025 |
News
Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
BAX launches FDA-cleared Connex 360 monitor, aiming to boost frontline care and streamline patient monitoring.
Read More
Is Now The Time To Buy Baxter Stock?
Published: August 26, 2025 by: Forbes
Sentiment: Negative
Baxter stock (NYSE: BAX), a healthcare company, has seen its stock decline by 14% over the past month. This drop followed a disappointing earnings report where the company also reduced its full-year guidance, partly due to Hurricane Helene impacting one of its manufacturing facilities.
Read More
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Published: August 01, 2025 by: Benzinga
Sentiment: Positive
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Read More
Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Negative
Baxter International (BAX) came out with quarterly earnings of $0.59 per share, missing the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.68 per share a year ago.
Read More
BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Negative
Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.
Read More
Baxter International Inc. (BAX) Q2 2025 Earnings Call Transcript
Published: July 31, 2025 by: Seeking Alpha
Sentiment: Neutral
Baxter International Inc. (NYSE:BAX ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair & Interim CEO Heather Knight - Executive Vice President & COO Joel T. Grade - Executive VP & CFO Conference Call Participants David Harrison Roman - Goldman Sachs Group, Inc., Research Division Lawrence H.
Read More
Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Baxter cuts forecast, misses estimates amid lingering hurricane impact on medical products unit
Published: July 31, 2025 by: Reuters
Sentiment: Negative
Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the lingering effect of Hurricane Helene, which damaged a key manufacturing facility and reduced demand for IV solutions.
Read More
Stay Ahead of the Game With Baxter (BAX) Q2 Earnings: Wall Street's Insights on Key Metrics
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for Baxter (BAX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Read More
Baxter Q2 Preview: Can Core Segments Deliver Another Solid Quarter?
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Positive
BAX aims for modest Q2 growth as core segments build on Q1 momentum and margin gains stabilize after recent recovery.
Read More
Medical Equipment Maker Baxter International Names New CEO
Published: July 07, 2025 by: Investopedia
Sentiment: Neutral
Baxter International on Monday named Andrew Hider, chief executive of Canadian automation solutions firm ATS Corp., its new CEO.
Read More
Mountain Heating and Cooling Transforms Historic Baxter Hotel with Innovative Mitsubishi Heat Pump Installation
Published: June 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
Bozeman, June 11, 2025 (GLOBE NEWSWIRE) -- Bozeman, Montana - Mountain Heating and Cooling recently shared details about their Mitsubishi Heat Pump Installation at the Historic Baxter Hotel in Bozeman Montana . The hotel needed a way to cool its event space while maintaining its historical charm.
Read More
BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Baxter launches Hemopatch Sealing Hemostat, an FDA-approved collagen pad designed for effective hemostasis and sealing in both open and minimally invasive surgeries.
Read More
4 Goldman Sachs Conviction List Top Picks Are Blue Chip Dividend Stock Royalty
Published: May 16, 2025 by: 24/7 Wall Street
Sentiment: Positive
The artificial intelligence rally over the past two and a half years, led by the so-called Magnificent 7, was remarkable if you owned those stocks.
Read More
The 'Goldilocks' Case For Baxter International
Published: May 08, 2025 by: Seeking Alpha
Sentiment: Neutral
Baxter International's stock has been challenging to own for the past decade, initially due to high valuations and later due to execution concerns and an ugly acquisition. During the pandemic, health care stocks, including Baxter, underperformed expectations, with BAX peaking in April 2020 before declining. But the divestiture of the kidney care business will help the balance sheet, and management is optimistic toward 2025 performance.
Read More
Baxter International Inc. (BAX) Q1 2025 Earnings Call Transcript
Published: May 01, 2025 by: Seeking Alpha
Sentiment: Neutral
Baxter International Inc. (NYSE:BAX ) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President and Chief Investor Relations Officer Brent Shafer - Chairman and Interim Chief Executive Officer Heather Knight - Chief Operating Officer Joel Grade - Executive Vice President and Chief Financial Officer Conference Call Participants Joanne Wuensch - Citi David Roman - Goldman Sachs Travis Steed - BofA Securities Vijay Kumar - Evercore ISI Robbie Marcus - JPMorgan Larry Biegelsen - Wells Pito Chickering - Deutsche Bank Danielle Antalffy - UBS Operator Good morning, ladies and gentlemen, and …
Read More
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts.
Read More
Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues.
Read More
Will BAX's Q1 Earnings Improve Following Transformation Completion?
Published: April 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Baxter's first-quarter results are likely to reflect the favorable impact of kidney care sales. Growth in infusion therapies, pharmaceuticals and patient support systems to continue.
Read More
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
Published: April 10, 2025 by: Business Wire
Sentiment: Neutral
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding or prevent leakage. The product is now available to order throughout Europe. “For over a decade, Hemopatch Sealing Hemostat.
Read More
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
Published: April 10, 2025 by: Business Wire
Sentiment: Neutral
VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the introduction of Hemopatch Sealing Hemostat with room temperature storage at a symposium in Austria. The evolution of the product optimizes accessibility in the operating room, delivering an immediate solution for surgeons to control bleeding or prevent leakage. The product is now available to order throughout Europe. “For over a decade, Hemopatch Sealing Hemostat.
Read More
Kontoor Brands CEO Scott Baxter sits down with Jim Cramer
Published: February 20, 2025 by: CNBC Television
Sentiment: Neutral
Kontoor Brands Chair, President, and CEO Scott Baxter joins 'Mad Money' host Jim Cramer to talk acquiring Helly Hansen, international business, and more.
Read More
BAX Stock Surges Following Q4 Earnings & Sales Beat, Margins Decline
Published: February 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Baxter reports better-than-expected fourth-quarter results. However, the company's gross and operating margins contract.
Read More
Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript
Published: February 20, 2025 by: Seeking Alpha
Sentiment: Neutral
Baxter International Inc. (BAX) Q4 2024 Earnings Conference Call Transcript
Read More
Baxter Q4 Earnings Beat Expectations, Issues Strong 2025 Outlook
Published: February 20, 2025 by: Benzinga
Sentiment: Positive
On Thursday, Baxter International Inc. BAX reported a fourth-quarter 2024 adjusted EPS of 58 cents, beating the management guidance of 50 cents-53 cents and the Wall Street estimate of 52 cents.
Read More
Baxter (BAX) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 20, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Baxter (BAX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Baxter to Present at Raymond James & Associates' 46th Annual Institutional Investors Conference
Published: February 17, 2025 by: Business Wire
Sentiment: Neutral
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James & Associates' 46th Annual Institutional Investors Conference on Monday, March 3, 2025. Joel Grade, Baxter's chief financial officer, is scheduled to present at 1:05 p.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through Saturday, August 30, 2025. About Baxter Every day, millions of.
Read More
Baxter Declares Quarterly Dividend
Published: February 11, 2025 by: Business Wire
Sentiment: Neutral
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on April 1, 2025, to stockholders of record as of Feb. 28, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter Every day, millions of patients, caregivers and healthcare providers rely on Baxter's leading portfolio of dia.
Read More
About Baxter International Inc. (BAX)
- IPO Date 1981-10-27
- Website https://www.baxter.com
- Industry Medical - Instruments & Supplies
- CEO David Brent Shafer
- Employees 38000